{"title":"Dynamic modifications of circular RNAs drive oncogenesis.","authors":"Jiaojiao Dai, Zhe Wang, Xiaoxun Cheng, Zhengze Hu, Jinghan Hua","doi":"10.1080/17501911.2025.2518918","DOIUrl":"https://doi.org/10.1080/17501911.2025.2518918","url":null,"abstract":"<p><p>Circular RNAs (circRNAs) are a class of covalently closed non-coding RNAs that regulate the progression of multiple cancers. Recent studies have revealed the presence of several post-transcriptional modifications such as N6-methyladenosine (m<sup>6</sup>A), N1-methyladenosine (m<sup>1</sup>A), 5-methylcytosine (m<sup>5</sup>C), N4-acetylcytidine (ac<sup>4</sup>C), and N7-methylguanosine (m<sup>7</sup>G) on circRNAs. This review synthesizes the results of articles retrieved through systematic searches of PubMed and Web of science databases, mainly focusing on circRNA modifications in cancers. These modifications affect the biogenesis, metabolism, stability, and function of circRNAs in cancers, highlighting the critical roles of circRNAs modifications in cancers. Moreover, circRNAs crosstalk with epigenetic modifications of mRNA across various cancers, offering new perspectives for cancer therapy. Innovations in detection techniques, such as anti-modifying antibodies and mass spectrometry, have improved the identification and sensitivity of epigenetically modified circRNAs. Emerging technologies including artificial intelligence (AI)-based bioinformatics algorithms will accelerate the development of RNA epigenetic modifications-based precision therapies. Herein, we summarize a range of epigenetically modified circRNAs and their future research directions. We hope to develop clinical protocols that targeting circRNAs modification for the treatment of refractory malignancies.</p>","PeriodicalId":11959,"journal":{"name":"Epigenomics","volume":" ","pages":"1-10"},"PeriodicalIF":3.0,"publicationDate":"2025-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144636595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
EpigenomicsPub Date : 2025-07-13DOI: 10.1080/17501911.2025.2530925
Jawad Akhtar, Vassiliki Saloura
{"title":"Bifaceted functions of histone methyltransferases.","authors":"Jawad Akhtar, Vassiliki Saloura","doi":"10.1080/17501911.2025.2530925","DOIUrl":"https://doi.org/10.1080/17501911.2025.2530925","url":null,"abstract":"<p><p>In this perspective, Akhtar et al provide a brief overview of Enhancer of Zeste Homolog 2 (EZH2) and SET and MYND-domain containing 3 (SMYD3) as histone methyltransferases that function both as activators and repressors of gene transcription in cancer. The importance of deciphering the mechanisms underlying this bifaceted function toward thoughtful pharmacologic interventions is underlined and protein or mRNA degradation are highlighted as the most biologically rational pharmaceutical platforms to target these bifaceted histone methyltransferases.</p>","PeriodicalId":11959,"journal":{"name":"Epigenomics","volume":" ","pages":"1-6"},"PeriodicalIF":3.0,"publicationDate":"2025-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144625640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Targeting Tudor domains in leukemia: epigenetic insights for drug development.","authors":"Aditi Pedgaonkar, Neha Niranjan, Aniruddha J Deshpande","doi":"10.1080/17501911.2025.2525746","DOIUrl":"https://doi.org/10.1080/17501911.2025.2525746","url":null,"abstract":"<p><p>Leukemia is a heterogeneous group of hematological malignancies characterized by uncontrolled proliferation and impaired differentiation of hematopoietic stem and progenitor cells. Epigenetic dysregulation is one of the critical drivers of leukemogenesis, often involving aberrant activity of chromatin-interacting proteins, such as readers, writers, and erasers. Tudor domain-containing proteins, such as SGF29, JMJD2A, 53BP1, Spindlin1, and UHRF1, play pivotal roles in leukemia progression by controlling key processes such as DNA damage response, transcriptional regulation, and RNA metabolism. Several recent efforts have aimed at pharmacologic targeting of the Tudor domain, opening a novel avenue for targeting epigenetic dysregulation. The review explores the structural characteristics of various Tudor domains, their binding preferences for specific histone modifications, and the consequences of these interactions for leukemia. By providing a comprehensive overview of current research, this review underscores the therapeutic potential of Tudor domain-targeting strategies in leukemia and emphasizes the need for further development of epigenetics-based treatment strategies to address resistance and relapse in these malignancies.</p>","PeriodicalId":11959,"journal":{"name":"Epigenomics","volume":" ","pages":"1-9"},"PeriodicalIF":3.0,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144583442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
EpigenomicsPub Date : 2025-07-06DOI: 10.1080/17501911.2025.2526320
Vasiliki Salameti, Ines M Tomas, David A Gunn
{"title":"Methylation levels in keratinocyte basal cells reflect donor age and associate with altered cellular proliferation pathways.","authors":"Vasiliki Salameti, Ines M Tomas, David A Gunn","doi":"10.1080/17501911.2025.2526320","DOIUrl":"https://doi.org/10.1080/17501911.2025.2526320","url":null,"abstract":"<p><strong>Aims: </strong>To determine if epigenomic and mRNA associations with donor age are present in basal keratinocytes <i>in vitro</i>.</p><p><strong>Methods: </strong>Whole-genome methylation (EPIC array), RNAseq analysis, and in vitro cell growth assessments were performed on cultured keratinocytes (<i>n</i> = 9, 22-68 years), enriched for cells expressing the stem cell protein markers ITGB1 and EpCAM.</p><p><strong>Results: </strong>Donor age associated with 1,244 differentially methylated positions (DMPs) (<i>p</i> < 0.01, >20% delta beta) and correlated with estimated ages from the Skin and Blood epigenetic clock (<i>r</i> = 0.83, <i>p</i> = 0.0018). The DMPs correlated with those in an <i>in vivo</i> epidermal dataset (<i>r</i> = 0.71, <i>p</i> < 0.0001). Donor age associated (<i>p</i> < 0.05) with 523 differentially expressed genes (DEGs), but the DEGs only weakly correlated with their changes in an <i>in vivo</i> epidermal dataset (<i>r</i> = 0.24, <i>p</i> < 0.0001). The \"cell growth and proliferation\" ontology term was significantly enriched in the methylation and expression datasets despite only 13 overlapping annotated genes. Decreased keratinocyte proliferation, increased differentiation and a reduced re-epithelialization ability were observed for an older versus a younger cell strain.</p><p><strong>Conclusion: </strong>Basal keratinocytes maintain <i>in vivo</i> age-associated epigenomic changes <i>in vitro</i> making them a good model for studying the impact of age-associated epigenomic changes on cellular function and behavior <i>in vitro</i>.</p>","PeriodicalId":11959,"journal":{"name":"Epigenomics","volume":" ","pages":"1-9"},"PeriodicalIF":3.0,"publicationDate":"2025-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144575111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"DNA methylation studies in mouse models of depression: a systematic review.","authors":"Mohammad Mustakim Billah, Chu Guo, Kazunari Mizuno, Yutaka Nakachi, Miki Bundo, Kazuya Iwamoto","doi":"10.1080/17501911.2025.2525750","DOIUrl":"https://doi.org/10.1080/17501911.2025.2525750","url":null,"abstract":"<p><strong>Background: </strong>Major depression (MD) is caused by both genetic and environmental factors. Epigenetic mechanisms, particularly DNA methylation (5mC) and hydroxymethylation (5hmC), are thought to mediate gene - environment interactions. However, findings in mouse models remain dispersed.</p><p><strong>Objective: </strong>This review evaluates the studies on 5mC and 5hmC in mouse models of depression.</p><p><strong>Methods: </strong>We systematically searched PubMed, Scopus, and Web of Science using terms related to 5mC/5hmC, depression, and mouse, until December 2024. We grouped the articles as candidate, global, cellular, and comprehensive studies and summarized the findings accordingly.</p><p><strong>Results: </strong>Sixty-eight studies met inclusion criteria. The main findings were environmental models, especially chronic stress paradigms, which were most frequently used to induce depression models. Candidate gene studies focused on Bdnf and Nr3c1, while global and cellular assays revealed both regional and widespread 5mC/5hmC changes. Genome-wide approaches revealed that epigenetic changes are not limited to isolated loci rather affect broad genomic regions involved in neural development and plasticity.</p><p><strong>Conclusion: </strong>This review provides a comprehensive summary of existing research on epigenetic changes in terms of DNA methylation in mouse models of depression. Broader application of standardized, integrative, and cell-type-specific approaches is needed to fully elucidate the role of epigenetic regulation in the pathology of MD.</p>","PeriodicalId":11959,"journal":{"name":"Epigenomics","volume":" ","pages":"1-13"},"PeriodicalIF":3.0,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144552732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
EpigenomicsPub Date : 2025-07-03DOI: 10.1080/17501911.2025.2525749
Christian Belton, Gavin Kelsey
{"title":"Mediators of maternal intergenerational epigenetic inheritance in mammals.","authors":"Christian Belton, Gavin Kelsey","doi":"10.1080/17501911.2025.2525749","DOIUrl":"https://doi.org/10.1080/17501911.2025.2525749","url":null,"abstract":"<p><p>Experimental models and epidemiological data suggest that environmental factors, for example, adverse nutrition prior to conception, can lead to phenotypes in offspring of exposed parents in the absence of continued exposure. As a result these phenotypes have been described as epigentically inherited. The mechanistic basis for such phenomena has not been established in most cases. In this review, we consider possible contributing mechanisms for environmentaly induced epigenetic inheritance, with a focus on maternally transmitted effects and by comparing to paradigms of epigenetic inheritance with a clear mechanistic understanding. Genomic imprinting has provided an important conceptual framework for how the epigenetic states of parental germlines can determine allelic expression in offspring, yet, generally speaking, imprinted genes appear resilient to epigenetic disruption from altered parental environments. Metastable epialleles are environmentally sensitive and variably expressed loci that can impact organism phenotype, but the nature of any epigenetic marker at these loci transferred to offspring is unclear. Studies of examples across these forms of epigenetic inheritance show predominant effects are mediated by oocyte factors involved inreprogramming of the genome post-fertilization, rather than direct effects on gametic DNA methylation, with the exception of genomic imprinting. The potential contribution of additional oocyte chromatin features to the specific liability of phenotypic effector genes and their potential to persist through this reprogramming, however, remains to be investigated.</p>","PeriodicalId":11959,"journal":{"name":"Epigenomics","volume":" ","pages":"1-9"},"PeriodicalIF":3.0,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144552733","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Methylation aberrations and genomic instability synergistically drive the evolution of intrahepatic cholangiocarcinoma.","authors":"Guanghao Li, Youhuang Bai, Feng Tao, Tingting Hu, Ting Wang, Yong Zeng, Deqiang Sun","doi":"10.1080/17501911.2025.2518919","DOIUrl":"10.1080/17501911.2025.2518919","url":null,"abstract":"<p><strong>Aims & methods: </strong>DNA methylation and genomic instability are critical drivers of cancer initiation and malignant progression. However, the roles of methylation aberrations and genomic instability in malignant progression have not been thoroughly investigated in intrahepatic cholangiocarcinoma (ICC). To address this, we identified differentially methylated regions (DMRs) and somatic copy number alterations (SCNAs) from 341 ICC samples across various stages.</p><p><strong>Results: </strong>Our findings revealed that stages IAIB, II, IIIA, and IIIB exhibited comparable methylation changes, whereas stage IV ICC showed a pronounced accumulation of stage-specific methylation alterations. Leveraging these findings, we developed a classification model that effectively distinguished stage IV ICC from earlier stages with high accuracy using 15 DMRs. Furthermore, stage IV ICC exhibited slightly higher genomic instability, including an elevated aneuploidy score and a greater proportion of focal amplifications. We also observed a positive correlation between SCNA burden and DNA methylation entropy in the promoter, gene body, and CpG island regions, with the gene body of <i>MDM2</i> serving as a notable example.</p><p><strong>Conclusions: </strong>These findings highlight the potential of DNA methylation as a biomarker for metastasis diagnosis and the interplay between local genomic instability and aberrant methylation, emphasizing their synergistic roles in driving the evolutionary trajectory of ICC.</p>","PeriodicalId":11959,"journal":{"name":"Epigenomics","volume":" ","pages":"661-674"},"PeriodicalIF":3.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12218711/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144316250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
EpigenomicsPub Date : 2025-07-01Epub Date: 2025-06-02DOI: 10.1080/17501911.2025.2508684
Connie J Mulligan
{"title":"Epigenetic age acceleration and psychosocial stressors in early childhood.","authors":"Connie J Mulligan","doi":"10.1080/17501911.2025.2508684","DOIUrl":"10.1080/17501911.2025.2508684","url":null,"abstract":"<p><p>The impact of psychosocial stress on mental and physical health is well-documented. Adverse experiences that occur early in life are particularly impactful on later life health. Epigenetic modifications, such as DNA methylation, have been proposed as a possible mechanism to mediate the impact of childhood events on adult health outcomes. The development of epigenetic clocks to estimate epigenetic age has revealed many examples of epigenetic age acceleration (and deceleration) in association with exposure to psychosocial stressors. Furthermore, altered epigenetic aging has been associated with downstream health outcomes. Here studies are discussed that have reported associations of epigenetic aging with early-life exposure to psychosocial stressors, such as childhood abuse and neglect, and with later-life health outcomes, including increased mortality, morbidity, and disease risk. Protective factors that may mitigate the effect of psychosocial stress on epigenetic aging, and possibly enable reversal of epigenetic aging, are also discussed.</p>","PeriodicalId":11959,"journal":{"name":"Epigenomics","volume":" ","pages":"701-710"},"PeriodicalIF":3.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12233885/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144198608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
EpigenomicsPub Date : 2025-07-01Epub Date: 2025-06-14DOI: 10.1080/17501911.2025.2518917
Meeshanthini Dogan, Robert Philibert
{"title":"Personalized medicine for cardiovascular diseases: how next generation epigenetic technologies can contribute?","authors":"Meeshanthini Dogan, Robert Philibert","doi":"10.1080/17501911.2025.2518917","DOIUrl":"10.1080/17501911.2025.2518917","url":null,"abstract":"<p><p>Advances in DNA methylation and artificial intelligence have led to new methods for assessing risk and diagnosing coronary heart disease (CHD), the leading cause of death. However, whether these technologies can also be harnessed to generate new pharmacotherapeutic agents or monitor the effectiveness of new or existing CHD therapies is unknown. In this perspective, we review the development of cardiac assessment technologies and the challenges that these older approaches attempted to address. We next describe Precision Epigenetic methods and describe their strengths and limitations, as well as the conceptual framework through which these tools operate. Finally, we discuss their potential application to the development and evaluation of new therapies for CHD and how Precision Epigenetic tools compare to existing testing modalities for CHD. We conclude that the future is bright for the use of Precision Epigenetic methods in cardiovascular medicine and suggest that their routine use could lead to faster, less expensive and more effective healthcare.</p>","PeriodicalId":11959,"journal":{"name":"Epigenomics","volume":" ","pages":"675-680"},"PeriodicalIF":3.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12233864/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144293477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}